Relating to the Texas Pharmaceutical Initiative.

HB 4638 amends Texas law to govern the Texas Pharmaceutical Initiative by increasing its governing board from three to five members appointed by the governor, with staggered six-year terms. The bill requires the board to submit an annual business plan by June 1 each even-numbered year, detailing implementation strategies for pharmacy benefit services, drug distribution networks, and advanced pharmaceutical services like generic drug manufacturing and gene therapies. The plan must also outline cost-saving measures, resource needs, conflict-of-interest procedures, and participation requirements for state health plans. This law, effective September 1, 2025, establishes the administrative framework for the initiative but does not directly alter healthcare access or costs for residents.